Invention Grant
- Patent Title: Parenteral dosage form of diltiazem
-
Application No.: US15780793Application Date: 2016-12-01
-
Publication No.: US11241379B2Publication Date: 2022-02-08
- Inventor: Samarth Kumar , Milan Natvarbhai Thakkar , Kandarp Maheshkumar Dave
- Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
- Applicant Address: IN Mumbai
- Assignee: SUN PHARMACEUTICAL INDUSTRIES LTD.
- Current Assignee: SUN PHARMACEUTICAL INDUSTRIES LTD.
- Current Assignee Address: IN Mumbai
- Agency: Blank Rome LLP
- Priority: IN4533/MUM/2015 20151201
- International Application: PCT/IN2016/050429 WO 20161201
- International Announcement: WO2017/094029 WO 20170608
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61J1/10 ; A61K31/554 ; A61K47/10
Abstract:
The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
Public/Granted literature
- US20200246254A1 PARENTERAL DOSAGE FORM OF DILTIAZEM Public/Granted day:2020-08-06
Information query
